APPY1 utilizes a multi biomarker test configuration with improved performance that has been validated in more than 500 patients through a successful pilot study.
Focused on laying a solid foundation with the expectation that 2014 maybe breakout year in terms of commercial activities
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.